Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Dendritic Cell Sarcoma, Interdigitating × Brentuximab Vedotin × 1 year × Clear all

Sponsor

Conditions

Hodgkin Disease 16 Lymphoma 6 Lymphoma, T-Cell, Cutaneous 5 Lymphoma, T-Cell 5 Mycosis Fungoides 4 Lymphoma, T-Cell, Peripheral 4 Lymphomatoid Papulosis 3 Lymphoma, Large-Cell, Anaplastic 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, Primary Cutaneous Anaplastic Large Cell 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Immunoblastic Lymphadenopathy 2 Hematologic Diseases 2 Enteropathy-Associated T-Cell Lymphoma 2 Squamous Cell Carcinoma of Head and Neck 1 Sezary Syndrome 1 Recurrence 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neoplasms 1 Mesothelioma, Malignant 1 Melanoma 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Leukemia, Large Granular Lymphocytic 1 Leukemia 1 Carcinoma, Non-Small-Cell Lung 1 Ann Arbor Stage IIB Hodgkin Lymphoma 1

Interventions

Cyclophosphamide 8 Whole-Body Irradiation 4 Rituximab 4 fludarabine phosphate 3 fludarabine 3 Mycophenolic Acid 3 Melphalan 3 Doxorubicin 3 polatuzumab vedotin 2 pirtobrutinib 2 glofitamab 2 Tacrolimus 2 Sirolimus 2 Prednisone 2 Busulfan 2 zanubrutinib 1 venetoclax 1 relmacabtagene autoleucel 1 pembrolizumab 1 pegfilgrastim 1 obinutuzumab 1 axicabtagene ciloleucel 1 Vincristine 1 Triamcinolone 1 Specimen Handling 1 Receptors, Chimeric Antigen 1 Prednisolone 1 Peripheral Blood Stem Cell Transplantation 1 Methotrexate 1 Magnetic Resonance Spectroscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡